Terms: = Ovarian cancer AND RANBP2, NUP358, 5903, ENSG00000153201, P49792, TRP1, TRP2
6 results:
1. Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei.
Lung MS; Mitchell CA; Doyle MA; Lynch AC; Gorringe KL; Bowtell DDL; ; Campbell IG; Trainer AH
BMC Cancer; 2020 May; 20(1):369. PubMed ID: 32357859
[TBL] [Abstract] [Full Text] [Related]
2. Exploring E-cadherin-peptidomimetics interaction using NMR and computational studies.
Civera M; Vasile F; Potenza D; Colombo C; Parente S; Vettraino C; Prosdocimi T; Parisini E; Belvisi L
PLoS Comput Biol; 2019 Jun; 15(6):e1007041. PubMed ID: 31158220
[TBL] [Abstract] [Full Text] [Related]
3. Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.
Fang H; Langstraat CL; Visscher DW; Folpe AL; Schoolmeester JK
Int J Gynecol Pathol; 2018 Sep; 37(5):468-472. PubMed ID: 28787324
[TBL] [Abstract] [Full Text] [Related]
4. Targeting zinc finger domains with small molecules: solution structure and binding studies of the ranbp2-type zinc finger of RBM5.
Farina B; Fattorusso R; Pellecchia M
Chembiochem; 2011 Dec; 12(18):2837-45. PubMed ID: 22162216
[TBL] [Abstract] [Full Text] [Related]
5. Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
Solár P; Sytkowski AJ
Cancer Lett; 2011 Oct; 309(1):11-8. PubMed ID: 21676537
[TBL] [Abstract] [Full Text] [Related]
6. Tissue specific promoters in targeting systemically delivered gene therapy.
Hart IR
Semin Oncol; 1996 Feb; 23(1):154-8. PubMed ID: 8607025
[TBL] [Abstract] [Full Text] [Related]
